Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate plus sulfalenepyrimethamine with or without praziquantel for schistosomiasis in Kenyan children
PACTR202211501227743Phase 3Completed
- Sponsor
- Kenya Medical Research Institute
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of artesunate and praziquantel in schistosomiasis (3 arms), sponsored by Kenya Medical Research Institute. Primary endpoint: Cure rate. Started Jan 2014; status: completed.
02
Drugs
artesunatepraziquantel
03
Conditions
schistosomiasis
Beyond the preview
Go deeper on PACTR202211501227743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202211501227743.